A randomized, open-label, multicenter study evaluating thrombovascular events (TVEs) in subjects with cancer receiving chemotherapy and administered epoetin alfa (EPO) once weekly (QW) or three times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results